Leading pro-life obstetrician-gynecologist discusses medical basis of mifepristone ruling
March 26, 2024
» Continue to this story on Wall Street Journal
CWN Editor's Note: In a Wall Street Journal op-ed, Dr. Christina Francis, the CEO of the American Association of Pro-Life Obstetricians and Gynecologists, discussed the 2023 federal appeals court ruling that found that the Food and Drug Administration acted improperly in broadening access to the abortion pill mifepristone.
“Under the FDA’s relaxed protocols, women are at far greater risk of a deadly ectopic pregnancy,” said Francis.
The Supreme Court is hearing the case on March 26.
The above note supplements, highlights, or corrects details in the original source (link above). About CWN news coverage.
For all current news, visit our News home page.
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
